Ironwood Pharmaceuticals, Inc. - Class A

Go to Ironwood Pharmaceuticals, Inc. - Class A Website

$0.80

0.00 (0.00%)
Live
Previous Close

$0.8046

Day Range

$0 - $0

Previous Day Range

$0.75 - $0.8157

Market Cap

$121.4 million USD

Day Vol.

0

Previous Day Vol.

936861

Currency

USD

Primary Exchange

Nasdaq

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Ironwood Pharmaceuticals' stock plunged after the FDA requested a confirmatory Phase 3 trial for its gastrointestinal drug apraglutide, despite strong data from the initial trial.

Related tickers: IRWD, GS, GSpA, GSpC, GSpD.

Read Full Article

Beam Therapeutics, a biotechnology company developing precision genetic medicines, has appointed Sravan K. Emany as its new Chief Financial Officer. Emany brings extensive experience in the life sciences industry and will help guide Beam's growth and capital allocation strategy.

Related tickers: BEAM, IRWD, IART, ASRT.

Read Full Article
Trending Tickers

Please sign in to view